via University of Aberdeen
A new drug being trialled for treating breast cancer and diabetes has been shown to ‘melt away’ the fat inside arteries that can cause heart attacks and strokes.
Researchers from the University of Aberdeen, using pre-clinical mouse models, showed that just a single dose of the drug (Trodusquemine) completely reversed the effects of a disease that causes a host of heart problems.
Atherosclerosis is the build-up of fatty material inside the arteries.
Over time this fatty material can grow bigger until your arteries become so narrow that not enough blood can pass through.
Atherosclerosis is the condition that causes most heart attacks and strokes.
In pre-clinical tests, mice with set-in atherosclerosis, mimicking what happens in humans, had less fatty plaques in their arteries whether they had regular doses over time or just a single dose of Trodusquemine.
The drug works by stopping an enzyme called PTP1B, which is normally increased in people with obesity or diabetes and conditions involving prolonged inflammation such as sepsis, inflamed diabetic foot ulcers and allergic lung inflammation. The researchers found that it also stimulated the action of another protein (AMPK), which effectively mimics exercise and reduces chronic inflammation.
It has already been shown to be effective with diabetes and breast cancer patients but this is the first time the drug has been shown to have benefits for long-term cardiovascular disease.
The £236,000 study was funded by the British Heart Foundation.
Professor Mirela Delibegovic and Dr Dawn Thompson from the University of Aberdeen’s Institute of Medical Sciences who led the study said: “All humans have some level of atherosclerosis. As you age you start to develop these fatty streaks inside your arteries. It is a big problem for people who are overweight or have underlying cardiovascular conditions.”
“Trodusquemine has already been trialled for treatment of diabetes and breast cancer but this is the first time it has been used in models of atherosclerosis.
“These have only been tested at pre-clinical level, in mice, so far but the results were quite impressive and showed that just a single dose of this drug seemed to completely reverse the effects of arthrosclerosis.
“The next step is to test the ability of this drug to improve outcomes in human patients with developed atherosclerosis and cardiovascular disease”.
Learn more: Drug ‘melts away’ fat inside arteries
The Latest on: Atherosclerosis
- Research: Mitochondrial DNA mutations associated with heart disease riskon August 5, 2022 at 9:25 am
During a recent study researchers have discovered how mitochondrial function, and dysfunction, play critical roles in numerous diseases, and even ageing. In a new study published in the online issue ...
- Study reverses long-held ideas about relationship among diabetes, fat and cardiovascular diseaseon August 5, 2022 at 8:58 am
A major risk factor for diabetes, insulin resistance occurs when the cells of the body do not respond to insulin and cannot make use of the glucose (sugar) in the blood stream. The condition is known ...
- Mitochondrial DNA mutations linked to heart disease riskon August 5, 2022 at 7:29 am
Researchers report a surprising link between mitochondria, inflammation and gene mutations that may increase risk of atherosclerosis.
- Mitochondrial DNA mutations are associated with an increased risk of atherosclerosison August 4, 2022 at 5:18 pm
Mitochondria are organelles found within most cells, best known for generating the chemical energy required to power cellular functions.
- UVA researchers receive $15 million from LeDucq Foundation to advance understanding of atherosclerosison August 3, 2022 at 9:41 am
The Boston-based LeDucq Foundation has awarded $15 million to researchers at UVA Health and their collaborators to advance our understanding of atherosclerosis, or hardening of the arteries ...
- Subclinical Atherosclerosis More Likely Among Young Black Adultson August 3, 2022 at 8:24 am
Socioeconomically vulnerable non-Hispanic Black young adults are more likely to have subclinical atherosclerosis than Hispanic young adults, according to a study published online ...
- $15 million from Leducq Foundation boosts UVA research to prevent heart attacks, strokeson August 3, 2022 at 5:04 am
The Boston-based LeDucq Foundation has awarded $15 million to researchers at UVA Health and their collaborators to advance our understanding of atherosclerosis, or hardening of the arteries, and find ...
- Scientists find surprising link between mitochondrial DNA and increased atherosclerosis riskon August 2, 2022 at 8:00 am
Mitochondria are known as cells' powerhouses, but mounting evidence suggests they also play a role in inflammation. Scientists from the Salk Institute and UC San Diego published new findings in ...
- Atherosclerosis Therapeutics Market is surge to witness Huge Demand at a CAGR 6.78% during the forecast period 2028on August 1, 2022 at 2:50 am
Atherosclerosis Therapeutics Market research report delivers a comprehensive analysis of the market structure along with ...
- Uterine myometrial calcification indicates atherosclerosis risk: Studyon July 27, 2022 at 9:30 pm
In a new study conducted by Rabia Akilli and colleagues, it has been determined that uterine myometrial calcification (UMC) is a standalone predictor of atherosclerosis risk. The findings of ...
via Google News and Bing News
